Objective This study aims to assess the prevalence of cancer risk factors in China’s working population and provide evidence for formulating more targeted workplace cancer prevention strategies.
BeOne Medicines, a global oncology company, today announced that Health Canada has granted a Notice of Compliance (NOC), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results